Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|May 29, 1998
Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemiaP Yotnda, H Firat, F Garcia-Pons, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on systemF Ginhoux, S Turbant, D A Gross, et al.
European Journal of Immunology|October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO miceH Firat, S Tourdot, A Ureta-Vidal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
An HLA-A2 polyepitope vaccine for melanoma immunotherapyL Mateo, J Gardner, Q Chen, et al.
British Journal of Cancer|July 3, 2003
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouseA Scardino, P Correale, H Firat, et al.
European Journal of Immunology|December 18, 2001
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumorsA Scardino, P Alves, D A Gross, et al.
Cardiology in the Young|January 28, 2021
Ligation of patent ductus arteriosus through anterior thoracotomy in preterm infants: a 10-year experienceArif Selcuk, Murat Cicek, Okan Yurdakok, et al.
Journal of Virology|June 11, 1999
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopesT Woodberry, J Gardner, L Mateo, et al.
British Journal of Haematology|November 14, 1997
The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcriptsA Baruchel, J M Cayuela, P Ballerini, et al.
Blood|November 5, 1997
Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autograftingM Lopez, F M Lemoine, H Firat, et al.
Pageof 4